24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Stock
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:20
Backline raises $9 million Seed round to eliminate security backlogs with autonomous AI
10:06
Intel spent $900 million on restructuring last year but enters 2025 on shaky ground
20:42
Beny Steinmetz faces extradition from Greece as corruption cases pile up
16:03
Full list of Israeli high-tech funding rounds in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Tenable acquiring Israel’s Vulcan Cyber in $150 million deal
2
Wiz uncovers major DeepSeek data exposure
3
Placer.ai lays off 150 employees in a push for profitability
4
Amazon and AWS CEOs make under-the-radar visit to Israel R&D center focused on chips
5
The DeepSeek watershed moment: Why an open-source AI model from China is reshaping the global tech scene
More news
Stock
3 stories about Stock
MediWound Loses Stock Purchase Agreement Case
14.11.17
|
Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
Allergan Planning Sale of its Teva Stock
01.11.17
|
Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Previous Articles